PMID- 30778846 OWN - NLM STAT- MEDLINE DCOM- 20200413 LR - 20200413 IS - 1708-0428 (Electronic) IS - 0960-8923 (Linking) VI - 29 IP - 6 DP - 2019 Jun TI - The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model. PG - 1889-1900 LID - 10.1007/s11695-019-03776-w [doi] AB - BACKGROUND: Gastric bypass with a proximal gastric pouch (Roux-en-Y gastric bypass) induces early diabetes remission. The effect of gastric bypass with a distal gastric pouch remains unknown. OBJECTIVE: To observe the effect on glucose tolerance and diabetes remission of gastric bypass with a distal gastric pouch. METHOD: A type 2 diabetes (T2D) model was created in 44 Sprague-Dawley (SD) rats that randomly underwent Roux-en-Y gastric bypass (RYGB, n = 8); gastric bypass with duodenal-jejunal transit (GB-DJT, n = 8); distal-pouch gastric bypass with duodenal-jejunal transit (DPGB-DJT, n = 8); distal-pouch gastric bypass with duodenal-jejunal bypass (DPGB-DJB, n = 8); sham (n = 6); and Roux-en-Y gastric bypass with esophageal re-anastomosis (RYGB-Er, n = 6) surgery. In the DPGB-DJT and the DPGB-DJB groups, the gastric pouch was created in the distal stomach. In the RYGB and the GB-DJT groups, the gastric pouch was created in the proximal stomach. An oral glucose tolerance test (OGTT), insulin tolerance test (ITT) and mixed-meal tolerance test (MMTT) conducted preoperatively were repeated postoperatively. RESULTS: GLP-1 AUC recorded preoperatively was significantly increased 8 weeks postoperatively in the RYGB, GB-DJT, and DPGB-DJB groups. Increased GLP-1 AUC in the DPGB-DJT did not reach statistical significance. Improved glucose tolerance in the RYGB and GB-DJT groups was significantly higher than DPGB-DJT group. DPGB-DJB did not improve glucose tolerance significantly. Gastrin level was increased significantly in the DPGB-DJT and DPGB-DJB groups. CONCLUSION: In gastric bypass, creating the gastric pouch in the distal region of the stomach significantly impairs the glucose tolerance and diabetes remission in spite of the increased GLP-1 and insulin responses in T2D SD rat model, suggesting that bypassing the distal stomach may be the key mediator of early diabetes remission after RYGB. FAU - Dolo, Ponnie Robertlee AU - Dolo PR AUID- ORCID: 0000-0002-6535-3574 AD - Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. AD - Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. FAU - Shao, Yong AU - Shao Y AD - Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. AD - Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. FAU - Li, Chao AU - Li C AD - Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. AD - Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. FAU - Zhu, Xiaocheng AU - Zhu X AD - Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. zhuxccf@163.com. AD - Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. zhuxccf@163.com. FAU - Yao, Libin AU - Yao L AD - Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. AD - Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. FAU - Wang, Hui AU - Wang H AD - Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. AD - Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, 221006, Jiangsu, People's Republic of China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Obes Surg JT - Obesity surgery JID - 9106714 RN - 0 (Biomarkers) RN - 0 (Blood Glucose) RN - 0 (Insulin) RN - 89750-14-1 (Glucagon-Like Peptide 1) SB - IM MH - Analysis of Variance MH - Animals MH - Biomarkers/metabolism MH - Blood Glucose/*metabolism MH - Diabetes Mellitus, Experimental/*metabolism MH - Diabetes Mellitus, Type 2/*metabolism/surgery MH - *Gastric Bypass/methods MH - Glucagon-Like Peptide 1/metabolism MH - Glucose Tolerance Test MH - Insulin/metabolism MH - Insulin Resistance/physiology MH - Male MH - Obesity, Morbid/metabolism/*surgery MH - Rats MH - Rats, Sprague-Dawley MH - Remission Induction OTO - NOTNLM OT - Distal stomach, antrum OT - Duodenal-jejunal bypass OT - Foregut OT - GLP-1 OT - Gastric bypass OT - Gastrin OT - Type 2 diabetes EDAT- 2019/02/20 06:00 MHDA- 2020/04/14 06:00 CRDT- 2019/02/20 06:00 PHST- 2019/02/20 06:00 [pubmed] PHST- 2020/04/14 06:00 [medline] PHST- 2019/02/20 06:00 [entrez] AID - 10.1007/s11695-019-03776-w [pii] AID - 10.1007/s11695-019-03776-w [doi] PST - ppublish SO - Obes Surg. 2019 Jun;29(6):1889-1900. doi: 10.1007/s11695-019-03776-w.